Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC

Tyrosine kinase inhibitors (EGFR-TKIs) targeting the epidermal growth factor receptor (EGFR) have been used in non-small cell lung carcinoma (NSCLC) for years with promising results, in particular in patients with activating mutations in the EGFR kinase domain (exon 19 E746-A750 deletion or exon 21...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zunyu, Song, Yan, Kai, Wang, Sun, Xilin, Shen, Baozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522229/
https://www.ncbi.nlm.nih.gov/pubmed/28489575
http://dx.doi.org/10.18632/oncotarget.17251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522229/
https://www.ncbi.nlm.nih.gov/pubmed/28489575
http://dx.doi.org/10.18632/oncotarget.17251

Ejemplares similares